Guggenheim initiated coverage on Neogen with a new price target
$NEOG
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Health Care
Guggenheim initiated coverage of Neogen with a rating of Buy and set a new price target of $15.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/19/2024 | $15.00 | Buy | Guggenheim |
| 6/16/2023 | $22.00 | Overweight | Wells Fargo |
| 11/22/2022 | Mkt Perform → Outperform | William Blair | |
| 7/12/2022 | $25.00 | Neutral | Piper Sandler |